You are required to be logged in to access the full website
Click here if you have forgotten your username or password
15 October 2024 - Clinical-stage biopharmaceutical company Saniona (STO:SANION) announced on Tuesday that its collaboration with Boehringer Ingelheim has advanced to lead optimization, triggering a EUR500,000 research milestone payment.This partnersh...
15 October 2024 - Clinical-stage biotechnology company Lipella Pharmaceuticals Inc (Nasdaq:LIPO) on Tuesday announced the receipt of a US patent for its proprietary liposomal drug delivery platform.The new patent covers key innovations in the company...
15 October 2024 - Clinical-stage biopharmaceutical company Adocia (Euronext Paris:ADOC) announced on Tuesday that it has filed patent applications for stable combinations of GLP-1 and amylin analogs for the treatment of obesity and diabetes using its...
15 October 2024 - US-based clinical-stage biotechnology company SystImmune, Inc announced on Monday that it has received US Food and Drug Administration clearance for its Investigational New Drug application for BL-M11D1, an antibody-drug conjugate t...
15 October 2024 - Pharmaceutical company Accord BioPharma, Inc., the US division of Intas Pharmaceuticals, announced on Monday that it has received US FDA approval for IMULDOSA (ustekinumab-srlf), a biosimilar to STELARA.IMULDOSA is approved to treat...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe